{"nct_id":"NCT00846989","title":"Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension","status":"COMPLETED","status_verified_date":"2013-02","start_date":"2009-01","start_date_type":null,"primary_completion_date":"2009-04","primary_completion_date_type":"ACTUAL","completion_date":"2009-04","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}